Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia - Top-Institutions - MDSpire

Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia

  • By

  • Michael R Hovan

  • Michael J Burkitt

  • Sierra A Derti

  • Judith U Hargrave

  • Angela S De Cordova

  • Matthew S Simon

  • Stephen G Jenkins

  • Lars F Westblade

  • Michael J Satlin

  • December 12, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Molecular Diagnostics

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Hematology-Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Translational Research

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Antimicrobial Stewardship

Original Source(s)

Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia

  • by Michael R Hovan, Michael J Burkitt, Sierra A Derti, Judith U Hargrave, Angela S De Cordova, Matthew S Simon, Stephen G Jenkins, Lars F Westblade, Michael J Satlin

  • December 12, 2025

Related Content

Hematopoietic cell transplantation and cell therapy activity landscape survey in the Kingdom of Saudi Arabia; a report from the Saudi Society of Blood and Marrow Transplantation (SSBMT)

Refining CAR-NK Design

Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.

  • March 4, 2026

  • 2 min
Meet the Team: Shernan Holtan, MD

The newest member of the cellular therapy research team and Chief of the Bone Marrow and Transplantation Service at Roswell Park Comprehensive Cancer Center is eager to continue advancing the field.

  • February 23, 2024

  • 2 min